Compare ABCL & WLFC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | ABCL | WLFC |
|---|---|---|
| Founded | 2012 | 1985 |
| Country | Canada | United States |
| Employees | N/A | 447 |
| Industry | Biotechnology: Pharmaceutical Preparations | Industrial Specialties |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.1B | 900.7M |
| IPO Year | 2020 | 1996 |
| Metric | ABCL | WLFC |
|---|---|---|
| Price | $3.55 | $134.20 |
| Analyst Decision | Buy | |
| Analyst Count | 5 | 0 |
| Target Price | ★ $7.75 | N/A |
| AVG Volume (30 Days) | ★ 3.6M | 44.2K |
| Earning Date | 11-06-2025 | 11-04-2025 |
| Dividend Yield | N/A | ★ 1.21% |
| EPS Growth | N/A | ★ 17.99 |
| EPS | N/A | ★ 16.70 |
| Revenue | $35,325,000.00 | ★ $674,381,000.00 |
| Revenue This Year | $25.45 | $16.17 |
| Revenue Next Year | $10.07 | $1.26 |
| P/E Ratio | ★ N/A | $7.91 |
| Revenue Growth | 7.17 | ★ 29.58 |
| 52 Week Low | $1.89 | $114.01 |
| 52 Week High | $6.52 | $229.67 |
| Indicator | ABCL | WLFC |
|---|---|---|
| Relative Strength Index (RSI) | 40.75 | 57.69 |
| Support Level | $3.32 | $130.05 |
| Resistance Level | $3.86 | $141.71 |
| Average True Range (ATR) | 0.19 | 5.08 |
| MACD | 0.04 | 1.02 |
| Stochastic Oscillator | 37.96 | 67.62 |
AbCellera Biologics Inc is an antibody discovery and development engine that's specifically designed to address the barriers of conventional discovery, finding the optimal clinical candidate with greater precision and speed, getting to the clinic and patients sooner. With the integrated AbCellera platform, the company's experts search a wide range of diverse antibodies to select the effective and developable leads fast and set partners up for enduring success. The company has extensive experience forging partnerships with emerging biotechs and pharmaceutical companies. AbCellera leverages proprietary hardware, software, and tools along with the latest data science, to operate as strategic partners and help develop optimized solutions faster for any program.
Willis Lease Finance Corp, with its subsidiaries, is a lessor and servicer of commercial aircraft and aircraft engines. The company has two reportable business segments, which include Leasing and Related Operations and Spare Parts Sales. A majority of its revenue is generated from the Leasing and Related Operations segment, which involves acquiring and leasing, under operating leases, commercial aircraft, aircraft engines, and other aircraft equipment and the selective purchase and resale of commercial aircraft engines, aircraft equipment, and other related businesses. Geographically, the company derives maximum revenue from the United States, followed by Europe, Asia-Pacific (excluding India), India, South America, Canada, Central America, and the Middle East.